4512.T | Wakamoto Pharmaceutical Co.,Ltd. Annual &

Annual Balance Sheets

(In JPY)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	15.42 Billion	15.71 Billion	14.95 Billion	14.57 Billion	15.98 Billion	17.76 Billion
Total Current Assets	8.96 Billion	9.35 Billion	8.6 Billion	7.63 Billion	8.64 Billion	9.62 Billion
Cash And Short Term Investments	3.66 Billion	3.87 Billion	3.23 Billion	2.84 Billion	2.88 Billion	3.26 Billion
Cash and Cash Equivalents	3.66 Billion	3.87 Billion	3.23 Billion	2.84 Billion	2.88 Billion	3.26 Billion
Short Term Investments	-	-	-	-	-	-69.98 Million
Net Receivables	2.87 Billion	3.33 Billion	2.93 Billion	2.81 Billion	3.25 Billion	3.75 Billion
Inventory	2 Billion	1.95 Billion	2.25 Billion	1.95 Billion	2.46 Billion	2.47 Billion
Other Current Assets	424.49 Million	185.24 Million	192.56 Million	20.61 Million	41.32 Million	134.1 Million
Total Non-Current Assets	6.45 Billion	6.35 Billion	6.34 Billion	6.93 Billion	7.33 Billion	8.13 Billion
Net PPE	3.02 Billion	3.03 Billion	3.29 Billion	3.52 Billion	3.64 Billion	3.9 Billion
Good Will And Intangible Assets	357.04 Million	202.06 Million	196.05 Million	201.27 Million	485.13 Million	472.13 Million
Good Will	-	-	-	-	-	-
Intangible Assets	357.04 Million	202.06 Million	196.05 Million	201.27 Million	485.13 Million	472.13 Million
Long-Term Investments	2.72 Billion	2.79 Billion	2.53 Billion	2.91 Billion	2.88 Billion	3.2 Billion
Tax Assets	3000.00	-2.79 Billion	-2.53 Billion	-2.91 Billion	-2.88 Billion	310.99 Million
Other Non Current Assets	339.24 Million	3.12 Billion	2.85 Billion	3.2 Billion	3.2 Billion	245.21 Million
Other Assets	-	3000.00	2000.00	2000.00	4000.00	2000.00
Total Liabilities	3.39 Billion	3.8 Billion	3.47 Billion	3.18 Billion	4.03 Billion	4 Billion
Total Current Liabilities	1.8 Billion	2.23 Billion	2 Billion	1.71 Billion	2.43 Billion	2.7 Billion
Account Payables	775.8 Million	1.04 Billion	1.1 Billion	829.34 Million	1.4 Billion	1.34 Billion
Tax Payables	27.81 Million	165.64 Million	71.27 Million	103.23 Million	34.94 Million	19.79 Million
Short Term Debt	100.52 Million	137.26 Million	127.54 Million	168.55 Million	161.73 Million	186.06 Million
Deferred Revenue	27.81 Million	1.02 Billion	734.52 Million	700.31 Million	850.4 Million	1.13 Billion
Other Current Liabilities	903.99 Million	34.96 Million	38.19 Million	14.51 Million	14.68 Million	39.1 Million
Total Non Current Liabilities	1.58 Billion	1.56 Billion	1.46 Billion	1.47 Billion	1.6 Billion	1.29 Billion
Long-Term Debt	-	529 Thousand	1.58 Million	2.64 Million	3.7 Million	2.13 Million
Deferred Revenue Non Current	-	1.05 Billion	1.08 Billion	1.05 Billion	1.07 Billion	-416.97 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.16 Billion	172.39 Million	171.63 Million	171.2 Million	170.23 Million	1.29 Billion
Other Liabilities	1.00	-	-	-	-	-
Total Equity	12.02 Billion	11.9 Billion	11.48 Billion	11.38 Billion	11.94 Billion	13.76 Billion
Stock Holders Equity	12.02 Billion	11.9 Billion	11.48 Billion	11.38 Billion	11.94 Billion	13.76 Billion
Common Stock	3.39 Billion	3.39 Billion	3.39 Billion	3.39 Billion	3.39 Billion	3.39 Billion
Retained Earnings	281.76 Million	753.46 Million	615.2 Million	384.71 Million	986.57 Million	2.64 Billion
Accumulated other comprehensive income	5.7 Billion	5.59 Billion	5.3 Billion	5.44 Billion	5.4 Billion	5.55 Billion
Common Stock Equity	12.02 Billion	11.9 Billion	11.48 Billion	11.38 Billion	11.94 Billion	13.76 Billion
Capital Lease Obligation	529 Thousand	1.58 Million	2.64 Million	3.7 Million	6.94 Million	5.33 Million
Total Investments	2.72 Billion	2.79 Billion	2.53 Billion	2.91 Billion	2.88 Billion	3.13 Billion
Total Debt	100.52 Million	137.79 Million	129.13 Million	171.2 Million	165.43 Million	188.2 Million
Net Debt	-3.56 Billion	-3.74 Billion	-3.1 Billion	-2.67 Billion	-2.71 Billion	-3.07 Billion

Breakdown	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2	2023 Q1
Total Assets	15.43 Billion	15.42 Billion	15.42 Billion	15.25 Billion	15.81 Billion	15.5 Billion
Total Current Assets	8.92 Billion	8.96 Billion	8.96 Billion	8.65 Billion	8.84 Billion	9.07 Billion
Cash And Short Term Investments	3.89 Billion	3.66 Billion	3.66 Billion	3.56 Billion	3.96 Billion	4.18 Billion
Cash and Cash Equivalents	3.89 Billion	3.66 Billion	3.66 Billion	3.56 Billion	3.96 Billion	4.18 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	2.6 Billion	2.87 Billion	2.87 Billion	2.64 Billion	2.46 Billion	2.63 Billion
Inventory	2.09 Billion	2 Billion	2 Billion	2.04 Billion	1.99 Billion	1.88 Billion
Other Current Assets	334.75 Million	424.49 Million	424.49 Million	402.09 Million	423.53 Million	378.97 Million
Total Non-Current Assets	6.51 Billion	6.45 Billion	6.45 Billion	6.6 Billion	6.96 Billion	6.42 Billion
Net PPE	2.99 Billion	3.02 Billion	3.02 Billion	3.07 Billion	3.03 Billion	3 Billion
Good Will And Intangible Assets	338.64 Million	357.04 Million	357.04 Million	325.42 Million	233 Million	204.97 Million
Good Will	-	-	-	-	-	-
Intangible Assets	338.64 Million	357.04 Million	357.04 Million	325.42 Million	233 Million	204.97 Million
Long-Term Investments	2.84 Billion	2.72 Billion	2.72 Billion	2.86 Billion	3.36 Billion	2.88 Billion
Tax Assets	-338.64 Million	3000.00	3000.00	1999.00	-3.36 Billion	-2.88 Billion
Other Non Current Assets	679.73 Million	339.24 Million	339.24 Million	337.62 Million	3.69 Billion	3.21 Billion
Other Assets	-	-	-	1.00	3000.00	2000.00
Total Liabilities	3.43 Billion	3.39 Billion	3.39 Billion	3.55 Billion	3.77 Billion	3.5 Billion
Total Current Liabilities	1.87 Billion	1.8 Billion	1.8 Billion	1.91 Billion	2 Billion	1.85 Billion
Account Payables	917.77 Million	775.8 Million	775.8 Million	973.64 Million	874.79 Million	802.83 Million
Tax Payables	15.46 Million	27.81 Million	27.81 Million	6.11 Million	32.24 Million	61.69 Million
Short Term Debt	100 Million	100.52 Million	100.52 Million	100 Million	100 Million	100 Million
Deferred Revenue	15.46 Million	27.81 Million	27.81 Million	6.11 Million	198.89 Million	131.31 Million
Other Current Liabilities	840.7 Million	903.99 Million	903.99 Million	835.02 Million	835.55 Million	823.05 Million
Total Non Current Liabilities	1.56 Billion	1.58 Billion	1.58 Billion	1.63 Billion	1.76 Billion	1.64 Billion
Long-Term Debt	-	-	-	-	-	-
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.16 Billion	1.16 Billion	1.16 Billion	1.15 Billion	1.18 Billion	1.22 Billion
Other Liabilities	-	1.00	1.00	1.00	-	-
Total Equity	12 Billion	12.02 Billion	12.02 Billion	11.7 Billion	12.03 Billion	12 Billion
Stock Holders Equity	12 Billion	12.02 Billion	12.02 Billion	11.7 Billion	12.03 Billion	12 Billion
Common Stock	3.39 Billion	3.39 Billion	3.39 Billion	3.39 Billion	3.39 Billion	3.39 Billion
Retained Earnings	4.59 Billion	281.76 Million	281.76 Million	4.39 Billion	4.37 Billion	4.7 Billion
Accumulated other comprehensive income	1.36 Billion	5.7 Billion	5.7 Billion	1.26 Billion	1.61 Billion	1.26 Billion
Common Stock Equity	12 Billion	12.02 Billion	12.02 Billion	11.7 Billion	12.03 Billion	12 Billion
Capital Lease Obligation	-	529 Thousand	529 Thousand	-	-	264 Thousand
Total Investments	2.84 Billion	2.72 Billion	2.72 Billion	2.86 Billion	3.36 Billion	2.88 Billion
Total Debt	100 Million	100.52 Million	100.52 Million	100 Million	100 Million	100 Million
Net Debt	-3.79 Billion	-3.56 Billion	-3.56 Billion	-3.46 Billion	-3.86 Billion	-4.08 Billion

Balance Sheet Charts

NIO Inc.

N3IA

Full Analysis

Annual Balance Sheets
Herfy Food Services Company

6002

Full Analysis

Annual Balance Sheets
Carel Industries S.p.A.

CRL

Full Analysis

Annual Balance Sheets
KEDE Numerical Control Co., Ltd.

688305

Full Analysis

Annual Balance Sheets
Technicolor SA

VANTI

Full Analysis

Annual Balance Sheets
Kukje Pharma Co., Ltd.

002720

Full Analysis

Annual Balance Sheets

Global Stocks Search

Wakamoto Pharmaceutical Co.,Ltd. (4512.T)

Annual Balance Sheets

Balance Sheet Charts

NIO Inc.

Herfy Food Services Company

Carel Industries S.p.A.

KEDE Numerical Control Co., Ltd.

Technicolor SA

Kukje Pharma Co., Ltd.